Rosetox – Botulinum Toxin Type A [South Korea]

Rosetox® – Botulinum Toxin Type A | South Korean Export-Grade Neurotoxin

Product Overview

Rosetox® is a Botulinum Toxin Type A developed and produced in South Korea, designed exclusively for overseas export markets. Manufactured in compliance with international GMP standards, Rosetox® provides a stable and effective solution for international partners seeking high-quality botulinum toxin products for non-clinical evaluation, research modeling, or product comparison studies.

Although newer to the international market compared to legacy brands, Rosetox® has established a growing presence due to its consistent performance, competitive pricing, and clean diffusion profile. This product is not approved for use within South Korea and is intended strictly for export purposes only.

---

Key Features & Advantages

• ✅ GMP-Certified South Korean Manufacturer
  Produced under pharmaceutical-grade conditions for export use.

• ✅ Stable Biological Activity
  Demonstrates consistent SNAP-25 cleavage action across tested batches.

• ✅ Clean Diffusion & Predictable Onset
  Suitable for modeling localized neuromuscular inhibition in research.

• ✅ Cost-Effective Alternative
  Positioned as a high-value option for distributors, laboratories, and regulatory comparison studies.

• ✅ Growing Global Export Presence
  Selected by importers in emerging markets seeking next-generation neurotoxins.

---

Product Specifications

• Product Name: Rosetox® – Botulinum Toxin Type A

• Active Ingredient: Clostridium botulinum toxin type A

• Form: Lyophilized powder

• Packaging: 100 Units / vial

• Appearance: White to off-white powder; becomes a clear solution upon reconstitution

• Origin: South Korea

• Manufacturer: Biopharma Korea

• Storage: 2°C–8°C refrigeration; reconstituted solution should be used within 24 hours

• Classification: Export Use Only – Not licensed for clinical or cosmetic use in the country of origin

---

Mechanism of Action

Rosetox® inhibits the release of acetylcholine at the neuromuscular junction by targeting the SNAP-25 protein within the SNARE complex. Once internalized into the neuron, the light chain of the toxin cleaves SNAP-25, disrupting neurotransmitter release and inducing temporary muscle paralysis.

This mechanism makes Rosetox® a relevant tool for investigating facial muscle control, localized wrinkle formation, neurotransmitter signaling pathways, and comparative botulinum efficacy. Its behavior is consistent with globally recognized Type A botulinum toxins.

Further reading: NIH Review – Botulinum Toxin Mechanism

---

Use Cases in Export Markets

• Market evaluation samples for international distributors

• Comparative botulinum toxin studies

• Pre-clinical laboratory modeling

• Neuromuscular inhibition testing

• Academic or R&D reference studies

---

Compliance Statement

This product is manufactured in South Korea and designated exclusively for export use. It is not registered or approved for clinical, therapeutic, or cosmetic application in the domestic market and must not be used for human or animal injection. All buyers, importers, and end users are responsible for ensuring compliance with the laws and regulations of their respective jurisdictions.

---

Tags / Keywords

Rosetox, Korean Botulinum Toxin, Botulinum Toxin Type A, Export-Only Neurotoxin, SNAP-25 Inhibition, Acetylcholine Blockade, Non-Clinical Botulinum, Emerging Toxin Brand, GMP Botulinum Korea, Comparative Toxin Research

---

External References

• NIH Mechanism of Botulinum Toxin

• WHO Botulinum Overview

• PubMed – Botulinum Toxin Type A